Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 May 19;25(1):396.
doi: 10.1186/s12887-025-05734-1.

Risk factors for mortality in children with moderate-to-severe ARDS with concurrent hematological or immune-related diseases: a retrospective analysis

Qingyue Wang  1   2 , Hongxing Dang  3 , Yueqiang Fu  1 , Chengjun Liu  1 , Jing Li  1 , Feng Xu  1
Affiliations
Observational Study

Risk factors for mortality in children with moderate-to-severe ARDS with concurrent hematological or immune-related diseases: a retrospective analysis

Qingyue Wang et al. BMC Pediatr. .

Abstract

Background: As a heterogeneous syndrome, acute respiratory distress syndrome (ARDS) patients with comorbidities are significantly more severely ill. We aim to investigate the clinical characteristics and analyze the risk factors for mortality in children with moderate-to-severe acute respiratory distress syndrome (ARDS) who also have concurrent hematological or immune-related diseases.

Methods: A retrospective observational study was conducted from September 2020 to May 2022 in the pediatric intensive care unit (PICU) at Children's Hospital of Chongqing Medical University (Chongqing, China). All children with moderate-to-severe ARDS were included and divided into two groups based on the presence or absence of hematological or immune-related diseases. Clinical characteristics, treatment, and outcome data were collected. Univariate logistic regression and multivariate Firth regression analysis were used to identify risk factors for mortality in children with moderate-to-severe ARDS with concurrent hematological or immune-related diseases.

Results: A total of 215 children with moderate-to-severe ARDS were included in the study, of whom 65 had hematological or immune-related diseases (30.2%). These children were older (p < 0.001), had higher Pediatric Index of Mortality 3 scores (p = 0.002), higher lactate levels (p = 0.042), higher rates of positive pathogen detection (p < 0.001), shorter PICU stay (p = 0.023), higher incidence of multiple organ dysfunction syndrome (p = 0.012), and higher 28-day mortality rates (p < 0.001). Firth regression analysis showed that invasive fungal infection (OR = 4.954, 95% CI 0.245-3.158, p < 0.05), use of vasoactive drugs (OR = 7.638, 95% CI 0.524-3.811, p < 0.05), and high-frequency oscillatory ventilation (OR = 6.551, 95% CI 0.134-3.908, p < 0.05) were associated with increased mortality rates in children with moderate-to-severe ARDS with concurrent hematological or immune-related diseases.

Conclusion: The incidence of moderate-to-severe ARDS is higher in children with concurrent hematological or immune-related diseases, and their prognosis is worse. In this group, children with invasive fungal infections, greater use of vasoactive drugs, or high-frequency oscillatory ventilation had a higher 28-day mortality rate.

Keywords: Acute respiratory distress syndrome; Children; Hematological or Immune-related diseases; Mortality.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki. This study obtained ethical approval from the Ethics Committee of the Children’s Hospital of Chongqing Medical University [File No.: (2019) Ethics Review (Research) No.(172)]. Informed consent was not applicable because the data were anonymized. Ethics Committee of the Children’s Hospital of Chongqing Medical University waived the need for patient informed consent due to retrospective analysis of medical records. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of screening PICU: Pediatric Intensive Care Unit; PALICC, Pediatric Acute Lung Injury Consensus Conference; PARDS: Pediatric Acute Respiratory Distress Syndrome
See this image and copyright information in PMC

References

    1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–23. - PubMed
    1. Schouten LR, Veltkamp F, Bos AP, van Woensel JB, Serpa Neto A, Schultz MJ, et al. Incidence and mortality of acute respiratory distress syndrome in children: A systematic review and Meta-Analysis. Crit Care Med. 2016;44(4):819–29. - PubMed
    1. Wong JJ, Phan HP, Phumeetham S, Ong JSM, Chor YK, Qian S, et al. Risk stratification in pediatric acute respiratory distress syndrome: A multicenter observational study. Crit Care Med. 2017;45(11):1820–8. - PubMed
    1. Laffey JG, Madotto F, Bellani G, Pham T, Fan E, Brochard L, et al. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017;5(8):627–38. - PubMed
    1. Azoulay E, Lemiale V, Mourvillier B, Garrouste-Orgeas M, Schwebel C, Ruckly S, et al. Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions. Intensive Care Med. 2018;44(7):1050–60. - PMC - PubMed

Publication types